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Abstract
Background: Activation-induced cytidine deaminase (AID) is a B-cell-specific DNA mutator that plays a key role in the
formation of the secondary antibody repertoire in germinal center B cells. In the search for binding partners, protein
coimmunoprecipitation assays are often performed, generally with agarose beads.
Methodology/Principal Findings: We found that, regardless of whether cell lysates containing exogenous or endogenous
AID were examined, one of two mouse AID forms bound to agarose alone.
Conclusions/Significance: These binding characteristics may be due to the known post-translational modifications of AID;
they may also need to be considered in coimmunoprecipitation experiments to avoid false-positive results.
Citation: Metzner M, Schuh W, Roth E, Ja ¨ck H-M, Wabl M (2010) Two Forms of Activation-Induced Cytidine Deaminase Differing in Their Ability to Bind
Agarose. PLoS ONE 5(1): e8883. doi:10.1371/journal.pone.0008883
Editor: Reuben S. Harris, University of Minnesota, United States of America
Received September 3, 2009; Accepted December 17, 2009; Published January 27, 2010
Copyright:  2010 Metzner et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Institutes of Health Grant R01AI041570 to Matthias Wabl and by the Research Grant JA968/5 through FOR832
from the Deutsche Forschungsgemeinschaft to Hans-Martin Ja ¨ck. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: mirjam.metzner@ucsf.edu
Introduction
Activation-induced cytidine deaminase (AID) is a B-cell-specific
DNA mutator that plays a key role in the formation of the
secondary antibody repertoire in germinal center B cells. AID is
the master protein for somatic hypermutation and class switching
of immunoglobulin genes, both of which are initiated by the
relatively small 24-kDa AID enzyme [1,2]. AID is almost
exclusively expressed in activated germinal center B cells [2].
With its nuclear localization signal and a nuclear export signal at
the N-terminus and C-terminus, respectively, AID shuttles
between the cytoplasm and the nucleus [3,4].
It is still a mystery how AID mediates two processes as
distinct as hypermutation and class switching, but it is thought
that specific cofactors interact with AID for control. While the
N-terminal domain of AID is required for hypermutation, the
C-terminal domain is essential for class switching but not for
hypermutation [5–8]. Factors interacting with AID might also
be needed to restrict the mutator activity of AID to the
immunoglobulin loci and protect genome integrity: For
example, constitutively expressed AID leads to T cell
lymphomas and lung micro-adenomas in transgenic mice [9],
and AID expression has been linked to oncogenic transloca-
tions [10,11] and inflammation-associated cancer [12–14]. But
the known AID-interacting proteins—replication protein A
[15], protein kinase A [16,17], DNA-dependent protein kinase
catalytic subunit [18], and the spliceosome-associated factor
CTNNBL1 [19]—do not have the specificity needed for these
functions.
In a widely used method to find factors binding to a protein of
interest, specific antibodies in combination with agarose beads are
added to cell lysates to coimmunoprecipitate these factors.
Commonly, the agarose beads are coupled with protein A or G,
both of which are bacterial cell wall components that bind to the
constant region of the heavy chain of antibodies. But it is well
known that some proteins tend to stick to the protein A or G, or to
the agarose itself. This problem can be avoided by performing a
pre-clearing step before the actual coimmunoprecipitation.
However, sometimes the protein of interest itself binds to the
beads. Then coimmunoprecipitation cannot be used without
modifying the protocol; or, worse, precipitated molecules give
false-positive results. If binding is of low affinity, the amount of
protein that adheres to the beads in a pre-clearing step will be
small, and there will be enough protein left to be precipitated in a
subsequent step, using specific antibody to either the protein of
interest or the putative binding partner. Alternatively, there are
two forms of the protein of interest—one binding to agarose (with
high affinity), the other not. We found that this is the case for AID,
i.e., that there are two forms that bind agarose differently.
Materials and Methods
Ethics Statement
All experiments with mice were performed following the
protocol AN077866-03B, most recently re-approved by the
IACUC on March 2009, as a yearly renewal. UCSF’s animal
house abides by all governmental regulations and standards,
Animal Welfare Assurance Number A3400-01.
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Primary splenic cells from BALB/c mice were cultured in
standard medium and stimulated with 50 mg/ml LPS (Sigma) and
100 ng/ml IL-4 (R&D Systems). After 4 days the activated B cells
were harvested and subjected to agarose binding assays. As
controls, B cells from age-and sex-matched AID
2/2 BALB/c mice
were cultured under the same conditions.
AID Induction in Stable HeLa Cell Transfectants
HeLa cells, stably transfected with a doxycycline-inducible
mouse wild-type AID construct [20] were induced with 1 mg/ml
doxycycline. After 24 hours, AID expressing cells were harvested
for further experiments.
AID Transfection of Phoenix Cells
Ecotropic-package Phoenix cells (of human embryonic kidney
cell origin) were transiently transfected (Lipofectamine; Invitrogen)
with the retroviral pCru plasmid [21] encoding the mouse wild-
type AID protein with or without N-terminal Flag-tag. As a
control, cells were transfected with the pCru plasmid encoding
GFP with or without N-terminal Flag-tag. Seventy-two hours after
transfection the cells were harvested and subjected to agarose
binding assays.
Agarose Binding Assay
LPS-and IL-4-stimulated wild-type and AID
2/2 B cells and
AID-and GFP-transfected Phoenixcells wereharvested and washed
twice with ice-cold PBS. Cells were resuspended in ice-cold Triton
lysis buffer (0.5% Triton X-100, 150 mM NaCl, 5 mM EDTA,
50 mM Tris pH 7.4, 15 mM NaN3, 1 mM PMSF, protease
inhibitor cocktail set V (Calbiochem)), incubated on ice for 30
minutes, and centrifuged at 11,000 g for 15 minutes at 4uC. The
supernatants were collected as the cleared lysates and used for the
agarose binding assay: Phoenix-AID or Phoenix-GFP lysate (5610
5
cells in100 ml of lysis buffer per sample) orLPS-and IL-4-stimulated
wild-type and AID
2/2 B cells (1610
7 in 100 ml of lysis buffer per
sample) were incubated with 30 ml of agarose beads (1st round) for
1 hour at 4uC on an orbital shaker. The unbound lysate was
incubated a second time with 30 ml of agarose beads (2nd round) for
1 hour at 4uC on an orbital shaker. The unbound lysates were
saved, and 1st and 2nd round beads were washed five times with
500 ml of ice-cold PBS and centrifuged after each washing step at
5,000 g for 3 minutes at 4uC. For the agarose binding assay in the
presence of RNase (only in the case of transfected, exogenous AID),
the samples were treated with RNase A (Roche) at concentrations of
0, 1 mg/ml (low), 100 mg/ml (medium), or 1 mg/ml (high) RNase
for 1 hour at room temperature before incubation with agarose
beads. The washed 1st and 2nd round beads and the unbound
lysate (supernatant) weremixed withSDS loading bufferand heated
for 10 minutes at 94uC before SDS-PAGE analysis and subsequent
transfer to a nitrocellulose membrane. The membrane was
incubated with primary and secondary antibodies, followed by
chemiluminescence.
For the detection of mouse AID, the mouse monoclonal anti-
mouse AID antibody AIDA 94.16 was used together with a
corresponding HRP-coupled secondary antibody. Antibody AIDA
94.16 was generated by immunizing BALB/c mice with a mix of
three different mouse AID peptides: peptide 1, AID aa position
13–27, YHFKNVRWAKGRHET; peptide 3a, AID aa position
61–74, FLRYISDWDLDPGR; and peptide 4, AID aa position
116–131, CEDRKAEPEGLRRLHR. Hybridoma supernatants
were tested on ELISA plates coated with mouse AID peptides and
by western blot analyses using cell lysates with endogenous or
Figure 1. Two AID variants with different agarose binding. Cell
lysates were incubated with agarose beads (1st Round). The unbound
lysate was incubated a second time with agarose beads (2nd Round).
The washed 1st and 2nd round beads and the unbound lysate after the
second incubation (Supernatant) were western blotted and developed
with a monoclonal anti-AID antibody. The positions of the molecular
mass standards are indicated next to the blots. (A) Endogenous AID:–
AID, lysate from AID-deficient cells; + AID, lysate from wild-type cells;
input equivalent to 2610
6 cells; 1st Round, 2nd Round, and
Supernatant, equivalent to 1610
7 cells. Exogenous AID:–AID, lysate
from GFP-transfected cells; + AID, lysate from AID-transfected cells;
input, 1st Round, 2nd Round, and Supernatant, all equivalent to 5610
5
cells. (B) Incubation with various Sepharose/agarose beads; exogenous
AID only. Sepharose is a trade name of agarose with some changes in
the charge of the polysaccharides. Protein G1 Sepharose and protein G2
Sepharose are protein G beads from different batches of the same
catalog number.
doi:10.1371/journal.pone.0008883.g001
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were subcloned via limiting dilution and tested again for AID
specificity.
The agarose binding assay using high molecular mass (HMM)
and low molecular mass (LMM) AID was performed as described
above; instead of unfractionated cell lysates, 100 ml of the relevant
1 ml size exclusion chromatography fractions were used. The
agarose binding assay using mouse wild-type AID expressed in E.
coli was performed as described above; instead of cell lysates, 2 mg
purified AID with N-terminal MBP-tag and, as a control, 2 mg
purified MBP were used. For the detection of AID-MBP and
MBP, the mouse monoclonal anti-MBP antibody M1321 (Sigma)
was used together with a corresponding HRP-coupled secondary
antibody.
As a positive control for the RNase treatment, 1 mg RNA was
incubated for 30 minutes at room temperature in the absence (\)
Figure 2. Agarose binding and immunoprecipitation of AID
and GFP. Lysates of 5610
5 Flag-AID-and Flag-GFP-transfected cells
were incubated with agarose beads (1st Round). In a second round, the
unbound lysate was incubated with 5 mg anti-AID or anti-Flag antibody
as indicated, and agarose beads were added (2nd Round + Antibody).
The washed 1st and 2nd round beads were western blotted. The
positions of the molecular mass standards are indicated next to the
blots. (A) Blot developed with a monoclonal anti-AID antibody. (B) Blot
developed with a monoclonal anti-Flag antibody.
doi:10.1371/journal.pone.0008883.g002
Figure 3. AID’s binding to agarose is not RNase sensitive. (A)
Agarose binding to AID in the absence (\) and presence of RNase A at
various concentrations: low (L) (1 mg/ml), medium (M) (100 mg/ml), or
high (H) (1 mg/ml). GFP control (–AID) or AID-transfected (+ AID)
human embryonic kidney cell lysates were treated with RNase and
incubated with two successive rounds of agarose beads (1st and 2nd
Round). The washed 1st and 2nd round beads and the unbound lysate
after the second bead incubation (Supernatant) were western blotted
and probed with a monoclonal anti-AID antibody. Input, 1st Round, 2nd
Round, and Supernatant, all equivalent to 5610
5 cells. The positions of
the molecular mass standards are indicated next to the blots. (B)
Incubation of 1 mg RNA in the absence (\) and presence of RNase A at
various concentrations: low (L) (1 mg/ml), medium (M) (100 mg/ml), or
high (H) (1 mg/ml). The positions of the size standards and the 18S and
28S rRNA are indicated next to the agarose gel.
doi:10.1371/journal.pone.0008883.g003
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ml), medium (M) (100 mg/ml), or high (H) (1 mg/ml). The
degradation of the RNA was analyzed on a 1% agarose gel.
The following beads were used for agarose binding assays: For
wild-type and AID
2/2 B cell lysates: protein G agarose (Thermo
Scientific, cat. #20398). For AID-and GFP-transfected Phoenix
cell lysates: protein G agarose (Thermo Scientific, cat. #20398),
protein A agarose (Thermo Scientific, cat. #20333), protein G
Sepharose (Sigma, cat. #P3296), calmodulin Sepharose (GE
Healthcare, cat. #17-0529-01), IgG Sepharose (GE Healthcare,
cat. #17-0969-01); anti-IgM agarose (Sigma, cat. #A4540), anti-
Flag agarose (Sigma, cat. #A2220), and anti-IgY agarose (Aves
Labs, cat. #P-1010). (Sepharose is a trade name of agarose with
some changes in the charge of the polysaccharides.)
Immunoprecipitation
Immunoprecipitation experiments were performed following
the agarose binding assay protocol with addition of an antibody-
antigen precipitation step. Between 1st and 2nd round beads
(protein G agarose, Invitrogen, cat. #15920-010) the lysate was
incubated with 5 mg precipitating antibody overnight at 4uC
(mouse monoclonal anti-AID antibody AIDA 94.16 or mouse
monoclonal anti-Flag antibody (Sigma, cat. #F1804)). For western
blotting of AID, the biotinylated anti-AID antibody AIDA 94.16
was used together with a Streptavidin HRP-coupled secondary
antibody; for western blotting of Flag-tagged proteins, a mouse
monoclonal anti-Flag antibody (Sigma, cat #F1804).
Results and Discussion
Two AID Variants within a Cell: One Binds to Agarose, the
Other One Does Not
In our studies to precipitate AID from cell lysates with antibody
to AID, we observed that mouse AID bound to agarose beads that
we added to the lysate in a pre-clearing step. Because such binding
stymied our attempts to immunoprecipitate AID, we investigated
this binding in greater detail. We considered two possibilities, and
combinations thereof: (i) AID binds to agarose (directly or
indirectly) with low affinity, in which case not all AID will be
removed from the cell lysate in the pre-clearing step. It will
therefore still be present in the precipitate generated in the second
round of binding, when agarose is added again; (ii) There are two
forms of AID, one that binds to agarose with high affinity and one
that does not.
We thus systematically performed agarose binding assays with
cell lysates containing endogenous or exogenous mouse AID. The
exogenous AID was produced by transfected Phoenix cells, and
the endogenous AID came from mitogen-and IL-4-stimulated
spleen cells from BALB/c mice. After incubating the lysates with
agarose beads, we incubated the unbound lysate a second time
with the beads. To test for the presence of AID, we then analyzed
the total cell lysate, the cell fraction bound to agarose, and the
unbound lysate (the supernatant after removal of the agarose
beads) on western blots (Figure 1). Both exogenous and
endogenous mouse AID strongly bound to agarose in the 1st
round but not in the 2nd (Figure 1A), even though there was still
much AID present (Figure 1A, Supernatant). These results imply
that there are two variants of AID present within a cell, one able to
bind to agarose, the other not.
To determine which component of the agarose beads was
responsible for the binding to AID, we performed binding assays
using agarose coupled with protein G, protein A, calmodulin or
(irrelevant) antibody. Since AID bound to all beads (Figure 1B), it
is thus the agarose to which AID binds. Noticeably, the ratio of
bound to unbound AID was variable to some extent (see, for
example, Figure 1A vs. Figure 1B); these differences in binding
efficiency of AID to beads may be explained by technical variation
between experiments, and by different binding capacity of the
Figure 4. Agarose binding of high molecular mass (HMM) and low molecular mass (LMM) AID complexes. (A) AID lysate, fractionated by
size exclusion chromatography, was incubated with agarose beads (1st Round). The unbound proteins were incubated a second time with agarose
beads (2nd Round). The proteins recovered from the washed 1st and 2nd round beads, and the unbound proteins after the second incubation
(Supernatant), were western blotted and developed with a monoclonal anti-AID antibody. The positions of the molecular mass standards are
indicated next to the blots. Lysate, unfractionated lysate from HeLa (–AID) and HeLa-AID (+ AID) cells; FPLC fractions, size-fractionated HMM and LMM
AID from HeLa-AID cells and primary blasts. (B) AID double band from endogenous (lysate from primary blasts), and exogenous (lysate from HeLa-AID
cells) AID.
doi:10.1371/journal.pone.0008883.g004
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the unbound fraction after agarose incubation, we detected AID
after precipitation with anti-AID and anti-Flag antibodies,
respectively (Figure 2, 2nd Round + Antibody). To exclude that
under the assay conditions of our experiments, any protein binds
to agarose in a similar manner as AID, we performed an agarose
binding assay using Flag-GFP cell lysates (Figure 2B). Unless a
specific antibody to it was added (Figure 2B, 2nd Round +
Antibody), GFP was not isolated from lysate with agarose
(Figure 2B, 1st Round).
AID Binding to Agarose Is Not RNase Sensitive
AID produced in insect cells needs to be treated with RNase to
be catalytically active [22]; therefore, AID may also interact with
RNA in mammalian cells. In that case, AID may bind to agarose
via the RNA. To investigate this question, we performed agarose
binding assays in the presence of increasing concentrations of
RNase A (Figure 3A). In these experiments, cell lysates were first
incubated with RNase and then with two successive rounds of
agarose (Figure 3A). To monitor RNase activity, 1 mg RNA
(mainly ribosomal RNA) was incubated in the presence of
increasing concentrations of RNase A (low, medium and high in
Figure 3B). Because RNase treatment did not affect the binding
ability of AID to agarose, we conclude that it is not the RNA that
mediates it.
Agarose Binding of High Molecular Mass (HMM) and Low
Molecular Mass (LMM) AID Complexes
To investigate whether the different agarose binding behavior of
AID could be explained by the presence or absence of additional
proteins that AID forms complexes with, we performed size
exclusion chromatography of AID positive cell lysates and did an
agarose binding assay with the fractionated high molecular mass
(HMM) and low molecular mass (LMM) AID protein complexes
(Figure 4A). In the case of exogenous AID expressed in HeLa cells,
the HMM AID bound to agarose, again with part of it not binding
(Figure 4A, HeLa HMM); the LMM AID however did not bind at
all (Figure 4, HeLa LMM). In the case of endogenous AID
expressed in stimulated B cells, both the HMM and the LMM
AID showed one part of AID binding, the other one not binding to
agarose (Figure 4A, Blasts). Although sometimes not visible due to
large amounts of protein present on the membranes and long
exposure of the films, both endogenous and exogenous AID are
usually represented by a double band (Figure 4B); and both
proteins of the AID doublet bind equally well to agarose
(Figure 4A).
For the experiments described above we used mouse AID
expressed in eukaryotic cells, but we also tested mouse AID
expressed in E. coli. The AID with an N-terminal maltose binding
protein (MBP)-tag behaved like the AID expressed in mouse cells:
one form bound to agarose, another did not (Figure 5, 1st, 2nd
Round, respectively). MBP alone did not bind to agarose (Figure 5,
1st and 2nd Round), confirming that it is the AID part of the AID-
MBP fusion protein that binds. Once again, binding to agarose
was not affected by RNase treatment of the sample beforehand
(Figure 5, lower panel).
Conclusions
Our finding that one form of AID strongly binds to agarose
beads complicates the interpretation of coprecipitation experi-
ments done to identify protein interaction partners of AID within a
cell. Especially when one does not incubate the protein lysate with
agarose beads alone, one cannot be sure about an actual
interaction. On the upside, two AID variants can be distinguished
by way of their difference in binding to agarose; endogenous and
exogenous AID display the same binding characteristic toward
agarose. It did not make a difference whether AID was expressed
in bacteria, or mouse and human cells; or whether AID was part of
the high or low molecular mass complex in activated B
lymphocytes. Nor did the two proteins represented by the AID
doublet differ in this regard. The two AID forms—binding and
non-binding—could represent different post-translational modifi-
cations. Some of the modifications determine the type of AID
activity, whether class switching or hypermutation [16,17,23–25].
But because AID expressed in bacteria did not show a difference,
the modifications need to be restricted to those also found in
bacteria.
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